BCRX FY 2019 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M+136.5% YoY

Gross Profit

$45M91.6% margin

Operating Income

-$99M-203.7% margin

Net Income

-$109M-223.0% margin

EPS (Diluted)

$-0.94

Cash Flow

Operating Cash Flow

-$90M

Free Cash Flow

-$90M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$175M

Total Liabilities

$137M

Stockholders' Equity

$38M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$21M	+136.5%
Gross Profit	$45M	$20M	+121.7%
Operating Income	-$99M	-$94M	-5.6%
Net Income	-$109M	-$101M	-7.6%